Overview
- 9 FDA inspections are on record.
- 7 inspections produced a Form 483.
- The most recent recorded inspection date is 2019-04-23.
At a glance
Inspections
9
Form 483s
7
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 16 Apr 2019 – 23 Apr 2019 | Animal Drugs & Feeds | 483 | View 483 → |
| 7 Jul 2017 – 14 Jul 2017 | Animal Drugs & Feeds | 483 | View 483 → |
| 14 Nov 2016 – 23 Nov 2016 | Animal Drugs & Feeds | 483 | View 483 → |
| 30 Nov 2015 – 4 Dec 2015 | Animal Drugs & Feeds | 483 | View 483 → |
| 3 Dec 2013 – 12 Dec 2013 | Animal Drugs & Feeds | 483 | On file |
| 21 Feb 2012 | Not recorded | 483 | View 483 → |
| 9 Jun 2010 | Not recorded | Clean | |
| 25 Jul 2008 | Not recorded | 483 | On file |
| 1 Feb 2001 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
Investigators
FDA investigators tied to this site in the record.
Zachary L Stamm2 insp.
Nathan R Moon2 insp.
Farhana Khan1 insp.
Zachary A Bogorad1 insp.
Gerard T Schneider1 insp.
Haroon Vohra1 insp.
Zachery L Miller1 insp.
Bryce A Hammer1 insp.
Jamie L Dion1 insp.
Kimberley A Hoefen1 insp.
Michael E Maselli1 insp.
Zachary A Miller1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.182 | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.160(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.180(e)(1) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.194(a)(4) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.56(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 226.1 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 226.30 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 226.40(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.81(b)(1)(ii) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Huvepharma, Inc.'s 7 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat